Huaxi Securities Co.Ltd(002926) maintain Acrobiosystems Co.Ltd(301080) buy rating: 22q1 performance continues to grow rapidly. It is planned to implement equity incentive and enhance the certainty of future performance growth

Huaxi Securities Co.Ltd(002926) 04 released the research report, saying that it maintained the buying rating of Acrobiosystems Co.Ltd(301080) ( Acrobiosystems Co.Ltd(301080) .sz, latest price: 125.25 yuan). The reasons for rating mainly include: 1) the performance of 22q1 continues to grow rapidly, and the non covid-19 business continues to grow rapidly; 2) It is planned to implement the restricted stock incentive plan in 2022 to enhance the future industry. Risk tips: failure risk of new product research and development, uncertainty risk of industry demand, uncertainty risk of covid-19 business, loss risk of core technicians and exchange rate fluctuation risk.

AI comments: Acrobiosystems Co.Ltd(301080) in the past month, it has received the attention of 6 research reports of securities companies and bought 4, with an average target price of 184.8 yuan, 59.55 yuan higher than the latest price of 125.25 yuan, and the average target price increased by 47.54%.

- Advertisment -